KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Cme (CME) over the last 17 years, with Q3 2025 value amounting to -$2.6 billion.

  • Cme's Enterprise Value fell 557.02% to -$2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 billion, marking a year-over-year decrease of 557.02%. This contributed to the annual value of -$3.0 billion for FY2024, which is 59.86% up from last year.
  • Per Cme's latest filing, its Enterprise Value stood at -$2.6 billion for Q3 2025, which was down 557.02% from -$2.1 billion recorded in Q2 2025.
  • Over the past 5 years, Cme's Enterprise Value peaked at -$1.0 billion during Q1 2021, and registered a low of -$3.0 billion during Q4 2023.
  • Over the past 5 years, Cme's median Enterprise Value value was -$2.1 billion (recorded in 2025), while the average stood at -$2.1 billion.
  • As far as peak fluctuations go, Cme's Enterprise Value plummeted by 11263.81% in 2022, and later surged by 2250.73% in 2023.
  • Cme's Enterprise Value (Quarter) stood at -$2.9 billion in 2021, then increased by 4.54% to -$2.8 billion in 2022, then decreased by 7.37% to -$3.0 billion in 2023, then increased by 0.6% to -$3.0 billion in 2024, then increased by 14.49% to -$2.6 billion in 2025.
  • Its last three reported values are -$2.6 billion in Q3 2025, -$2.1 billion for Q2 2025, and -$1.5 billion during Q1 2025.